Thursday, July 9, 2026

biotech · Relapsed/Refractory Multiple Myeloma · Respiratory Distress Syndrome, Adult · INKT

MiNK Therapeutics

MiNK Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

NEW YORK, NY, SE HQ
2012 Founded
9 Employees
Public company Type
INKT · NYSE Ticker
Company details
Status
Public
HQ
NEW YORK, NY, SE
Founded
2012
Employees
9
Programs
3
Drugs
1
Patents
6
Intelligence · Clinical Trials

MiNK Therapeutics clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to MiNK Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

MiNK Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for MiNK Therapeutics.

  1. agenT-797 — Phase 1

    Clinical update
  2. agenT-797 — Phase 1

    Clinical update
  3. agenT-797 — Phase 1

    Clinical update

Trial registry

3 studies